25 Aug How to Be an Amazing Reviewer
Register below to receive Zoom link
This session will provide attendees with insight into the critical role of manuscript reviewers in the overall editorial process. The role of reviewing in career development will also be discussed. Examples of effective reviews will be provided. Current standards for reproducibility and scientific conduct will be reviewed. Attendees will gain expertise on how to write a strong paper as they learn more about how to write an excellent review.
Event Materials4 MBSLIDE PRESENTATION – How to be an Amazing Reviewer
At the end of the session:
- Attendees will be able to complete a professional review within a reasonable period of time.
- Attendees will be able to interact effectively with editors and editorial staff.
- Attendees will become more proficient in writing their own manuscripts.
Attendees are invited to have on hand a review that is in progress or completed, and/or a manuscript that they have been asked to review or would have liked to review. These are for self-reflection during the learning session, and/or may provide a basis for further discussion.
Schedule of Activities
- 12:00-12:10pm – Welcome, Overview, Introductions
- 12:10-1:25pm – Presentation and Q&A
- 1:25-1:30pm – Thank You and Feedback Survey
About the Speaker
Dr. Kathryn (“Kay”) Meier currently serves as Interim Chair and Professor of Pharmaceutical Sciences at Washington State University College of Pharmacy and Pharmaceutical Sciences. She trained at the University of California San Diego, University of Wisconsin, and University of Washington, and held previous faculty appointments at the UW and at Medical University of South Carolina (MUSC). Her research in cellular signal transduction, resulting in 87 peer-reviewed publications, has been funded by grants from NIH, NSF, DOD, Ferring Research Institute, and the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dr. Meier has been honored with awards for her efforts in mentoring and promoting STEM diversity.
At the national level, Dr. Meier serves as a reviewer for multiple government agencies (VA, DOD, NSF, NIH). With respect to professional societies, she is particularly active as a member of ASPET, where she has served as an officer in the Division of Molecular Pharmacology, member of the Board of Publication Trustees, Associate Editor for the Journal of Pharmacology and Experimental Therapeutics, and currently as Editor-in-Chief of Molecular Pharmacology. She has also been active in the American Physiological Society (APS), serving on the editorial board of the American Journal of Physiology (Cell Physiology), and as a member of the APS Science Policy Committee. Dr. Meier is a Fellow of ASPET, APS, and the American Association for the Advancement of Science (AAAS), and is a member of the Washington State Academy of Sciences.